Aiming to drug genetic modifiers, Roche-partnered biotech bags $31M to fuel a drive toward clinic

Over the past year and a half since Scenic Biotech signed its discovery pact with Roche’s Genentech, the partners have expanded the deal twice so that the small Dutch biotech would deploy its target discovery platform in six scientific areas.

Now, Scenic is deciding it’s time to invest on its own pipeline.